Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

LITHIUM CARBONATE

All products: general benefit

Lithane · DIN 02013231 · 150mg · capsule

General benefitMarketed · checked 2026-09-20
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Lithane · DIN 02013231 Manufacturer: Searchlight Pharma Inc.; listing date 1996-10-01 Health Canada: Marketed since 2022-09-23 · brand LITHANE · ATC N05AN01 LITHIUM · form Capsule · route Oral · ingredients LITHIUM CARBONATE 150 MG · company Searchlight pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

Ministry pays: $0.0667 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13626 · Verify on the e-Formulary ↗ (DIN 02013231)

Source record
DIN 02013231: Lithane Raw flags: sec3=Y Item: 281612014; group id 512; item number 1353; lccId None; manufacturer id SLP Source form: Cap; strength: 150mg Recorded listing: General benefit Source prices (unrounded): $0.1892; ministry $0.0667 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02013231 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13626
Interchangeable products
Apo-Lithium Carbonate · DIN 09857532 · $0.0667
Shortage status: not checked (no credentials)
Other drugs in the same formulary class (28:16:12 Other Psychotropics) and how they are covered

Matched class: 28:16:12 Other Psychotropics

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. No displayed product is listed as a general benefit in this extract. Check its listing requirements below. 28:16:12 Other Psychotropics

TRYPTOPHAN

· 11 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 500mg, 750mg, 1g · Cap, Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 28:16:12
Full class listing Related classes: 28:08:04 Nonsteroidal Anti-Inflammatory Agents, 28:08:08 Opiate Agonists, 28:08:12 Opiate Partial Agonists, 28:08:92 Miscellaneous Analgesics and Antipyretics, 28:16:04 Antidepressants, 28:16:08 Tranquilizers, 28:36:08 Anticholinergic Agents, 28:36:20 Dopamine Receptor Agonists Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS LITHANE (lithium carbonate) is indicated for:  the treatment of acute manic episodes in patients with manic-depressive disorders. Maintenance therapy has been found useful in preventing or diminishing the frequency of subsequent relapses in bipolar manic-depressive patients (with a strong history of mania). 1.1 Pediatrics Pediatrics (<18 years of age): Health Canada has not authorized an indication for pediatric use (see 7.1.3 Pediatrics). 1.2 Geriatrics Evidence from clinical studies and experience suggests that use in the geriatric population is associated with differences in safety or effectiveness (see 7.1.4 Geriatrics). https://pdf.hres.ca/dpd_pm/00067512.PDF PM date: SEP 21, 2022 Source product: LITHANE; DIN 00406775; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.